COO COOPER COMPANIES, INC.

CIK 0000711404 44 ready 8-Ks latest June 4, 2026, 4:27 PM ET RSS · JSON

Activity: QUIET 0 filings / 30d vs 1 baseline

Ready 8-Ks 44

Latest filing June 4, 2026, 4:27 PM ET

Top materiality 0.90

Event mix earnings ×19 · leadership ×9 · other_material ×5

Sentiment 17 pos · 0 neg · 27 neu

Latest earnings reported 2026-Q1

Executive change recent →

Recent 8-K filings for COO

Highest-materiality recent filing

CooperCompanies Q2 revenue $1.082B (+8% YoY); non-GAAP EPS $1.21 (+26%); records $271.6M litigation charge

June 4, 2026, 4:27 PM ET other material materiality 0.90 positive item 2.02 item 8.01 item 9.01 ◈ Earnings Releases ×2

Revenue $1.082B (+8% reported, +5% organic); CooperVision $723.5M (+8%), CooperSurgical $358.0M (+8%).
GAAP diluted EPS of $(0.40) due to $271.6M net litigation charge; non-GAAP diluted EPS $1.21, up 26% YoY.

Read filing →

June 4, 2026, 4:27 PM ET other material materiality 0.90 positive item 2.02 item 8.01 item 9.01 ◈ Earnings Releases ×2

CooperCompanies Q2 revenue $1.082B (+8% YoY); non-GAAP EPS $1.21 (+26%); records $271.6M litigation charge

Revenue $1.082B (+8% reported, +5% organic); CooperVision $723.5M (+8%), CooperSurgical $358.0M (+8%).
May 4, 2026, 7:59 PM ET leadership materiality 0.25 neutral item 5.02 item 7.01 item 9.01 ◈ executive_change

CooperCompanies appoints Paul Keel to Board of Directors effective July 1, 2026

Board size increased from 9 to 10 directors; Keel fills new director seat.
April 8, 2026, 7:59 PM ET other material materiality 0.15 neutral item 5.07 item 9.01

Cooper Companies announces results of 2026 annual meeting; all proposals pass

All nine director nominees elected with >92% of votes cast (excluding broker non-votes).
March 5, 2026, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases

CooperCompanies Q1 revenue $1.024B, non-GAAP EPS $1.10; raises FY2026 guidance

Q1 revenue $1.024B (+6% reported, +3% organic); GAAP EPS $0.66 (+27%), non-GAAP EPS $1.10 (+20%).
February 4, 2026, 6:59 PM ET debt materiality 0.55 neutral item 1.01 item 9.01 ◈ Material Agreements ×2

Cooper Companies extends $950M term loan maturity to 2031, removes credit spread adjustment

Extended $950M of term loans to maturity date February 3, 2031; $550M remain at original maturity.
December 23, 2025, 6:59 PM ET leadership materiality 0.65 neutral item 1.01 item 5.02 item 7.01 item 9.01 ◈ Material Agreements

CooperCompanies appoints former STERIS CEO Rosebrough to board; agrees with Browning West

Walter M. Rosebrough Jr., former STERIS CEO, appointed as independent director effective Jan 3, 2026; joins Governance & Nominating Committee.
December 12, 2025, 6:59 PM ET leadership materiality 0.10 neutral item 5.02 item 9.01

Cooper Companies CFO Andrews adds principal accounting officer role

Brian G. Andrews, EVP/CFO/Treasurer, assumed principal accounting officer duties on Dec 9, 2025.
December 4, 2025, 6:59 PM ET earnings materiality 0.90 positive item 2.02 item 5.02 item 7.01 item 9.01

CooperCompanies reports Q4 FY2025 revenue up 5%, appoints new Chairman, launches strategic review

Q4 FY2025 revenue $1,065.2M (+5% reported, +3% organic); GAAP EPS $0.43 (-27%), non-GAAP EPS $1.15 (+11%)
August 27, 2025, 7:59 PM ET earnings materiality 0.80 neutral item 2.02 item 9.01

CooperCompanies Reports Q3 2025 Revenue of $1.0603B, Up 6%; Non-GAAP EPS $1.10, Up 15%

Revenue grew 6% to $1,060.3 million; CooperVision up 6% to $718.4M, CooperSurgical up 4% to $341.9M.
May 29, 2025, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

CooperCompanies Q2 revenue $1.00B, up 6% YoY; non-GAAP EPS $0.96 (+14%)

Revenue $1,002.3M (+6% YoY); GAAP EPS $0.44 flat; non-GAAP EPS $0.96 (+14%).
April 30, 2025, 7:59 PM ET leadership materiality 0.50 neutral item 5.02 item 7.01 item 9.01 ◈ executive_change

CooperCompanies appoints Barbara Carbone to Board of Directors, effective May 1, 2025

Board expanded from 7 to 8 directors; Carbone appointed as independent director.
April 2, 2025, 7:59 PM ET other material materiality 0.15 neutral item 5.07 item 9.01

Cooper Companies annual meeting elects directors, passes officer exculpation amendment

All seven director nominees elected including Colleen Jay, Lawrence Kurzius, Cynthia Lucchese, Teresa Madden, Maria Rivas, Robert Weiss, Albert White.
March 6, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

CooperCompanies Q1 revenue $964.7M (+4% YoY); non-GAAP EPS $0.92; raises FY EPS outlook to $3.94-$4.02

Revenue $964.7M (+4% reported, +5% constant currency, +5% organic); GAAP diluted EPS $0.52 (vs $0.41), non-GAAP diluted EPS $0.92 (vs $0.85).
February 5, 2025, 6:59 PM ET leadership materiality 0.20 neutral item 5.02 item 9.01 ◈ executive_change

Cooper Companies director William A. Kozy to retire at April 2025 annual meeting

William A. Kozy informed the Board he will retire as director effective at the 2025 Annual Meeting in April.
December 5, 2024, 6:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01

CooperCompanies Q4 revenue $1.02B (+10% YoY), non-GAAP EPS $1.04, up 19%; FY25 guide $4.08-$4.16B

Q4 revenue $1,018.4M (+10% YoY), GAAP EPS $0.58 (+38%), non-GAAP EPS $1.04 (+19%).
October 25, 2024, 7:59 PM ET other materiality 0.15 neutral item 5.03 item 9.01 ◈ Governance Changes

Cooper Companies amends bylaws with universal proxy and exclusive forum provisions

Bylaw amendments include universal proxy rule compliance and white proxy card reserved for Board.
August 28, 2024, 7:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01

CooperCompanies Q3 revenue up 8% to $1,002.8M; raises FY 2024 guidance

Revenue $1,002.8M (+8% YoY); GAAP diluted EPS $0.52 (+22%), non-GAAP diluted EPS $0.96 (+14%).
May 30, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

CooperCompanies Q2 revenue $942.6M (+7% YoY), raises FY2024 guidance

GAAP diluted EPS $0.44 (up 122% YoY); non-GAAP diluted EPS $0.85 (up 10% YoY).
May 1, 2024, 7:59 PM ET debt materiality 0.50 neutral item 1.01 item 1.02 item 2.03 item 9.01 ◈ Material Agreements ×3◈ Debt Financings

Cooper Companies enters $2.3B revolving credit facility, terminates prior facility

New $2.3B multicurrency revolver with $1B sublimit for non-USD borrowings, maturing May 1, 2029.
March 22, 2024, 7:59 PM ET other materiality 0.15 neutral item 5.07 item 9.01 ◈ Shareholder Votes ×3

Cooper Companies stockholders elect 8 directors at 2024 annual meeting

All eight director nominees elected; highest votes for Albert G. White III (44,225,910 for) and Cynthia L. Lucchese (43,915,382 for).
February 29, 2024, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases

Cooper Q1 revenue record $931.6M (+9% YoY); non-GAAP EPS $0.85 (+18%); FY24 guidance raised

Revenue of $931.6M, up 9% YoY; CooperVision $621.5M (+7%), CooperSurgical $310.1M (+12%).
February 16, 2024, 6:59 PM ET other materiality 0.30 neutral item 3.03 item 5.03 item 8.01 item 9.01 ◈ Governance Changes

CooperCompanies announces 4-for-1 stock split effective Feb. 16, 2024

Stock split ratio 4:1; effective 5:00 PM ET on Feb 16; trading starts split-adjusted Feb 20.
December 14, 2023, 6:59 PM ET leadership materiality 0.25 neutral item 5.02 item 9.01 ◈ executive_change

Cooper Companies director Gary Petersmeyer to retire at March 2024 annual meeting

Gary S. Petersmeyer notified the Board of his retirement effective at the 2024 Annual Meeting in March 2024.
December 7, 2023, 6:59 PM ET earnings materiality 0.80 positive item 2.02 item 8.01 item 9.01 ◈ Earnings Releases ×3

Cooper Q4 revenue $927M (+9%); FY2024 guidance $3.81-3.88B; 4-for-1 stock split

Q4 GAAP diluted EPS $1.70 (+29%); non-GAAP diluted EPS $3.47 (+26%). FY GAAP EPS $5.91 (-24%), non-GAAP $12.81 (+3%).
November 30, 2023, 6:59 PM ET leadership materiality 0.25 neutral item 5.02 item 7.01 item 9.01 ◈ executive_change

CooperCompanies appoints Lawrence E. Kurzius to board as independent director

Board expanded from eight to nine directors; Kurzius effective Dec 1, 2023.
September 12, 2023, 7:59 PM ET other material materiality 0.30 neutral item 3.01 item 7.01 item 9.01

CooperCompanies to transfer stock listing from NYSE to Nasdaq, effective September 26, 2023

Board authorized voluntary delisting from NYSE; last trading on NYSE expected September 25, 2023.
August 30, 2023, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

CooperCompanies Q3 revenue $930.2M (+10% YoY); non-GAAP EPS $3.35 (+5%); guides FY23 revenue $3.578-3.595B

Revenue $930.2M up 10% YoY; record quarterly revenue for both CooperVision and CooperSurgical.
June 1, 2023, 7:59 PM ET earnings materiality 0.70 neutral item 2.02 item 9.01 ◈ Earnings Releases

Cooper Q2 revenue up 6% to $877M; GAAP EPS slumps 69% to $0.80; FY23 guidance updated

Revenue $877.4M, up 6% YoY (9% constant currency, 8% organic); GAAP diluted EPS $0.80 vs $2.55 last year.
March 16, 2023, 7:59 PM ET other materiality 0.10 neutral item 5.07 item 9.01 ◈ Shareholder Votes ×5

Cooper Companies annual meeting approves all proposals including LTIP and auditor ratification

All 8 director nominees elected; votes for ranged from 39.8M to 44.5M; broker non-votes 1.6M.
March 2, 2023, 6:59 PM ET earnings materiality 0.75 neutral item 2.02 item 9.01

CooperCompanies Q1 revenue up 9% to $858.5M; guides FY23 non-GAAP EPS $12.60-$12.90

Revenue $858.5M, up 9% YoY (16% constant currency, 10% organic).
December 19, 2022, 6:59 PM ET leadership materiality 0.30 neutral item 5.02 item 9.01 ◈ executive_change

Director Jody S. Lindell to retire at March 2023 annual meeting

Director Jody S. Lindell will retire from the Board effective at the company's March 2023 Annual Meeting.
December 8, 2022, 6:59 PM ET earnings materiality 0.70 neutral item 2.02 item 9.01 ◈ Earnings Releases ×3

CooperCompanies Q4 revenue up 12% to $848M, but GAAP EPS falls 40%; FY2023 guidance issued

Q4 GAAP diluted EPS of $1.32 (down 40% YoY); non-GAAP diluted EPS of $2.75 (down 16%).
October 4, 2022, 7:59 PM ET leadership materiality 0.30 neutral item 5.02 item 7.01 item 9.01 ◈ executive_change

CooperCompanies appoints Cynthia Lucchese to Board of Directors, effective Oct 1, 2022

Cynthia Lucchese appointed as independent director, expanding board from 8 to 9 members.
August 31, 2022, 7:59 PM ET earnings materiality 0.75 neutral item 2.02 item 9.01

Cooper Q3 revenue $843.4M (+10% YoY); non-GAAP EPS $3.19 down 6%; FY22 guide $3.29-3.31B

Revenue $843.4M (+10% YoY); CooperVision +2% to $566.3M, CooperSurgical +35% to $277.1M.
June 2, 2022, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

CooperCompanies Q2 rev up 15% to $829.8M; GAAP EPS $2.55, adj EPS $3.24

CooperVision revenue $553.8M (+6% reported, +12% organic); toric and multifocal sales strong.
March 18, 2022, 7:59 PM ET other materiality 0.10 neutral item 5.07

Cooper Companies annual meeting results: all directors elected, auditor ratified, say-on-pay passes

All eight director nominees elected; highest vote count for Maria Rivas (43.7M for) and Albert White (43.5M for).
March 3, 2022, 6:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

CooperCompanies Q1 revenue up 16% to $787M; non-GAAP EPS $3.24

Revenue $787.2M (+16% YoY); CooperVision +11% to $561.5M, CooperSurgical +30% to $225.7M.
February 7, 2022, 6:59 PM ET M&A materiality 0.80 positive item 1.01 item 7.01 item 9.01

CooperCompanies to acquire Cook Medical's Reproductive Health business for $875M

Deal consideration: $675M at closing plus $200M in four $50M annual installments.
December 17, 2021, 6:59 PM ET M&A materiality 0.85 neutral item 1.01 item 2.01 item 2.03 item 7.01 item 9.01

CooperCompanies completes $1.6B acquisition of Generate Life Sciences, funded by $1.5B term loan

Cooper completed acquisition of Generate Life Sciences for ~$1.605B in cash.
December 10, 2021, 6:59 PM ET other material materiality 0.35 neutral item 5.02 item 9.01

Cooper Companies adopts 2022 Incentive Payment Plan; CEO target 125% of salary

CEO Albert White receives 125% target eligibility; Threshold Goal requires 50% achievement of Revenue, Income, or EPS.
December 2, 2021, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

CooperCompanies reports record FY2021 revenue; Q4 revenue up 11% to $759.1M

Q4 revenue $759.1M (+11% YoY); GAAP EPS $2.21 (+35%); Non-GAAP EPS $3.28 (+4%)
November 10, 2021, 6:59 PM ET M&A materiality 0.75 positive item 1.01 item 7.01 item 9.01

CooperCompanies to acquire Generate Life Sciences for $1.6B cash, expected to close Q1 2022

CooperSurgical unit will acquire Generate, a provider of donor egg/sperm, fertility cryopreservation, and newborn stem cell storage.
November 5, 2021, 7:59 PM ET debt materiality 0.50 neutral item 1.01 item 2.03 item 9.01

Cooper enters $840M 364-day unsecured term loan to replace maturing facility

Term loan of $840M matures Nov 1, 2022; replaces prior 364-day facility that matured Oct 15, 2021.
September 2, 2021, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

Cooper Q3 revenue up 32% to $763.4M; non-GAAP EPS $3.41, up 50%; raises FY guidance

Revenue $763.4M (+32% YoY); CooperVision $557.5M (+24%), CooperSurgical $205.9M (+60%).

Executive changes

Appointed

Paul Keel

Director

COO · COOPER COMPANIES, INC.

Effective: 2026-07-01
Filed: May 4, 2026, 7:59 PM ET

approved the appointment of Paul Keel to fill the new director position, effective as of July 1, 2026

Appointed

Barbara Carbone

Director

COO · COOPER COMPANIES, INC.

Effective: 2025-05-01
Filed: April 30, 2025, 7:59 PM ET

to appoint Barbara Carbone to fill the new director position, with effect from May 1, 2025

Departed

William A. Kozy

Director

COO · COOPER COMPANIES, INC.

Filed: February 5, 2025, 6:59 PM ET

On January 31, 2025, William A. Kozy informed the Board of Directors (the "Board") that he will retire as a director, effective on the date of The Cooper Companies, Inc.'s (the "Company's") next Annual Meeting of Stockholders in April 2025 (the "Annual Meeting").

Departed

Gary S. Petersmeyer

director

COO · COOPER COMPANIES, INC.

Filed: December 14, 2023, 6:59 PM ET

On December 12, 2023, Gary S. Petersmeyer informed the Board that he will retire as a director, effective on the date of the Company's next Annual Meeting of Stockholders in March 2024.

Appointed

Lawrence E. Kurzius

Director

COO · COOPER COMPANIES, INC.

Effective: 2023-12-01
Filed: November 30, 2023, 6:59 PM ET

the Board of Directors of the Company (the “Board”) voted to expand the size of the Board from eight directors to nine directors with effect from December 1, 2023 and to appoint Lawrence E. Kurzius to fill the new director position, with effect from December 1, 2023

Departed

Jody S. Lindell

Director

COO · COOPER COMPANIES, INC.

Filed: December 19, 2022, 6:59 PM ET

On December 13, 2022, Jody S. Lindell informed the Board that she will retire as a director, effective on the date of the Company’s next Annual Meeting of Stockholders in March 2023.

Appointed

Cynthia L. Lucchese

Director

COO · COOPER COMPANIES, INC.

Effective: 2022-10-01
Filed: October 4, 2022, 7:59 PM ET

to elect Cynthia L. Lucchese to fill the new director position, with effect from October 1, 2022

Earnings & guidance

2026-Q1 EPS reported $0.66 filing →

Materiality & sentiment trend

Max materiality 0.90 · Median 0.70 · Most common event earnings

17 positive 0 negative 27 neutral

source · COO on sec.gov